SCHEMBL14640449

SCHEMBL14640449

CC(C)(C)c1ccc(-c2cncc(C(=O)NC3CCCCC3)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ RXFP1 Q9HBX9 1/20 0.53
▸ EPHX1 P07099 1/20 0.50
▸ EPHX2 P34913 1/20 0.50
▸ RAB9A P51151 4/20 0.49
▸ NPC1 O15118 4/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ ABL1 P00519 1/20 0.47
▸ BCR P11274 1/20 0.47
▸ ALPL P05186 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ XDH P47989 2/20 0.45
▸ SMYD3 Q9H7B4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14640428 0.89 ABL1 (0.49) KMT2AMEN1RAB9ANPC1SMN1; SMN2
SCHEMBL3456068 0.82 RAB9A (0.71) KMT2AMEN1EPHX1EPHX2RAB9A
SCHEMBL10212094 0.82 RAB9A (0.71) KMT2AMEN1EPHX1EPHX2RAB9A
SCHEMBL14640427 0.81 TSHR (0.53) KMT2AMEN1KDM4ERAB9ANPC1
SCHEMBL5606272 0.81 MEN1 (0.74) KMT2AMEN1SMN1; SMN2CYP1A2CYP2C19
SCHEMBL13483865 0.80 RAB9A (0.68) KMT2AMEN1EPHX1EPHX2RAB9A
SCHEMBL17806746 0.79 MKNK1 (0.52) EPHX2XDH
SCHEMBL19445672 0.79 KMT2A (0.63) KMT2AMEN1KDM4ERXFP1RAB9A
SCHEMBL28125494 0.77 XDH (0.61) KMT2AMEN1KDM4ERXFP1RAB9A
SCHEMBL14640451 0.77 DRD2 (0.67) KMT2AMEN1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007011760-A2 INHIBITORS OF MITOTIC KINESIN KALYPSYS, INC. (US) 2007-01-25 — — WO disclosed
Send feedback